A glutathione and ultrasound dual‐responsive cerasome achieves sequential co‐delivery of gemcitabine and BMS1166 in tumors. Chemotherapy priming followed by on‐demand PD‐L1 blockade synergistically amplifies anti‐tumor immunity, inhibiting primary tumor growth, distant metastasis and inducing durable immune memory.
Suhui Sun +9 more
wiley +1 more source
Overexpression of interleukin-4 using adeno-associated virus is a potential strategy to enhance bone regeneration. [PDF]
Kim H +5 more
europepmc +1 more source
TP53 Loss Elevates NF‐κB‐IFN‐β‐MHC‐Ia Signaling to Promote NK Cell Resistance in Osteosarcoma
TP53 loss in a transforming or osteosarcoma cell promotes cytosolic DNA accumulation, activating NF‐κB‐dependent IFN‐β production. Autocrine IFN‐β signaling increases cell‐surface HLA‐Ia expression, strengthens inhibitory KIR signaling in natural killer cells, and thereby enables the affected cell to evade NK cell‐mediated cytotoxicity.
Guihui Qin +9 more
wiley +1 more source
Clinical significance of serum interleukin-4, interleukin-12, interleukin-13, and transforming growth factor-β levels in children with sleep-disordered breathing. [PDF]
Du Y +5 more
europepmc +1 more source
Impact of Newcastle disease virus vaccines and genetic variations on interleukin-4 activation in broiler chicken. [PDF]
Edan RJ, Jumaa RS.
europepmc +1 more source
Trem2 acts as a non-classical receptor of interleukin-4 to promote diabetic wound healing. [PDF]
Zhu X +11 more
europepmc +1 more source
The E3 ligases Itch and WWP2 regulate autoimmune neuroinflammation by controlling T<sub>H</sub>2 to T<sub>H</sub>17 cell conversion via interleukin-4-STAT5 axis in mice. [PDF]
Zhao M +5 more
europepmc +1 more source
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors. [PDF]
Arnold L +10 more
europepmc +1 more source
Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission. [PDF]
Al-Ahmad M, Ali A, Talat W.
europepmc +1 more source

